FERRIPROX DR Trademark

Trademark Overview

On Thursday, February 27, 2020, a trademark application was filed for FERRIPROX DR with the United States Patent and Trademark Office. The USPTO has given the FERRIPROX DR trademark a serial number of 88812657. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 10, 2023. This trademark is owned by CHIESI FARMACEUTICI S.p.A.. The FERRIPROX DR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, a metal chelating agent for use as therapy in treating disorders of iron metabolism or overload
ferriprox dr

General Information

Serial Number88812657
Word MarkFERRIPROX DR
Filing DateThursday, February 27, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 14, 2020

Trademark Statements

Description of MarkThe mark consists of a butterfly in blue, stylized wording "Ferriprox" in red and stylized wording "DR" in blue.
Goods and ServicesPharmaceutical preparations, namely, a metal chelating agent for use as therapy in treating disorders of iron metabolism or overload
Indication of Colors claimedThe color(s) Blue and Red is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"DR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCHIESI FARMACEUTICI S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressPARMA 43122
IT
Party NameCHIESI FARMACEUTICI S.p.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressPARMA 43122
IT

Trademark Events

Event DateEvent Description
Monday, April 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 10, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 25, 2022SOU EXTENSION 4 GRANTED
Thursday, August 25, 2022SOU EXTENSION 4 FILED
Thursday, August 25, 2022TEAS EXTENSION RECEIVED
Tuesday, March 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 4, 2022SOU EXTENSION 3 GRANTED
Friday, March 4, 2022SOU EXTENSION 3 FILED
Friday, March 4, 2022TEAS EXTENSION RECEIVED
Saturday, August 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 26, 2021SOU EXTENSION 2 GRANTED
Thursday, August 26, 2021SOU EXTENSION 2 FILED
Thursday, August 26, 2021TEAS EXTENSION RECEIVED
Friday, February 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 1 GRANTED
Wednesday, February 10, 2021SOU EXTENSION 1 FILED
Wednesday, February 10, 2021TEAS EXTENSION RECEIVED
Tuesday, September 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 23, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 23, 2020NON-FINAL ACTION E-MAILED
Saturday, May 23, 2020NON-FINAL ACTION WRITTEN
Wednesday, May 13, 2020ASSIGNED TO EXAMINER
Friday, March 6, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 5, 2020NEW APPLICATION ENTERED

Related Keywords

ferriprox disorders treating iron metabolism overload therapy agent preparations namely metal